STAT+: Novo Nordisk’s semaglutide fails to slow Alzheimer’s progression

Two trials testing the Novo Nordisk weight loss drug semaglutide in Alzheimer’s disease failed, the company said Monday, showing the medicine did not slow the progression of the condition versus placebo.  Studying semaglutide — the key ingredient in the blockbusters Ozempic and Wegovy — in Alzheimer’s was always seen as a long shot, even as […]

Singer Lizzo reveals she was frustrated being ‘overshadowed’ by her ‘fatness’

American singer Lizzo, has revealed that she was frustrated by being ‘overshadowed’ by her ‘fatness’ in a candid new post reflecting on her weight loss journey. The 37-year-old singer has dramatically slimmed down in recent years after years of embracing her role as the face of the body positivity movement. In her very first Substack post, entitled ‘Why is everybody losing weight […]

Consider these 3 shares to buy before the Christmas boom

The festive season is an interesting time for the stock market, presenting unique opportunities for shares to buy while other companies take leave. Naturally, retail and e-commerce businesses see the largest boost, while tourism and luxury-related stocks also tend to benefit. Here are three stocks that I think are worth considering as Christmas draws closer. […]

Shaily Engineering shares up 3%; UBS initiates buy with 60% upside potential

UBS has initiated coverage on Shaily Engineering Plastics with a Buy rating and a target price of Rs 4,000, citing strong growth prospects driven by its patented technology, upcoming GLP-1 generic launch, and improving utilisation across consumer and industrial segments. The brokerage expects robust earnings growth and market share gains supported by high entry barriers […]

Study finds GLP-1 drugs improve strength and reverse aging biology in mice

Researchers showed that GLP-1 receptor agonism counteracts aging across multiple organs in mice, improving strength and reversing molecular aging signatures without meaningful effects on body weight. These benefits depended largely on hypothalamic GLP-1R signaling and closely mirrored the anti-aging patterns produced by rapamycin.